A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis
NCT ID: NCT02398292
Last Updated: 2019-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2015-02-28
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis
NCT02155699
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
NCT00655239
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
NCT00338832
Culturally Responsive Person-Centered Care for Psychosis
NCT00231933
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
NCT01907282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
M3 Program
Non-randomized experimental group. The program is a six-week multi-modal intervention, including nutrition education and cooking classes, physical activity, and mindfulness. Outcomes will be compared to a non-randomized control group.
M3 Program
Participants and their study partners will learn about food, movement, and mindfulness through hands-on curriculum.
Control
Non-randomized control group. Outcomes will be compared at same time points (baseline, 6 weeks, 12 weeks).
Control
Participants will not participate in M3 program but will have same outcomes measured at same time points (baseline, 6 weeks, 12 weeks).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
M3 Program
Participants and their study partners will learn about food, movement, and mindfulness through hands-on curriculum.
Control
Participants will not participate in M3 program but will have same outcomes measured at same time points (baseline, 6 weeks, 12 weeks).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Established mental health provider and primary care physician.
* Age 15 to 25 years (inclusive)
* Able to enroll with a study partner (study partner can be a healthy volunteer)
* Able to read and write in English
Exclusion Criteria
* Mental status exam which suggests high risk for disruptiveness to group process or danger to self and others.
* If a graduate of EASA, the participant must have a primary care or mental health provider.
15 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lynne Shinto
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynne Shinto, ND, MPH
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Craigan Usher, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health and Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10376
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.